Tumor Virology, Immunology & Cellular Pathology

An oncovirus is an infection that can cause disease. any infection with a DNA or RNA genome causing disease and is synonymous with "tumor virus" or "cancer virus". DNA oncoviruses ordinarily divide into two groups of tumor silencer proteins: tumor proteins p53 and the retinoblastoma proteins (Rb). It is developmentally favourable for infections to inactivate p53 on the grounds that p53 can trigger cell cycle capture or apoptosis in contaminated cells when the infection endeavours to reproduce its DNA.

Cancer immunology is an interdisciplinary part of science that is worried about understanding the job of the resistant framework in the movement and improvement of disease; the most notable application is cancer growth immunotherapy, which uses the invulnerable framework as a treatment for disease.

 

  • Human oncoviruses
  • DNA viruses
  • RNA viruses
  • Tumor antigens
  • Cancer immunoediting
  • Mechanisms of tumor evasion from the immune response
  • Cancer immunology and chemotherapy

Related Conference of Tumor Virology, Immunology & Cellular Pathology

April 28-29, 2025

35th Experts Meet On Cancer Research & Therapy

Paris, France
May 26-27, 2025

15th World Congress on Breast Cancer

Rome, Italy
June 16-17, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
July 14-15, 2025

5th World Congress on Breast Cancer

Berlin, Germany
July 28-29, 2025

45th Euro Congress on Cancer Science & Therapy

Paris, France
August 18-19, 2025

6th Cancer Diagnostics & Treatment Conference

Rome, Italy
October 13-14, 2025

8th International Conference on Anti-Cancer Drugs & Therapies

Aix-en-Provence, France
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain
November 24-25, 2025

43rd World Cancer Conference

Barcelona, Spain

Tumor Virology, Immunology & Cellular Pathology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in